Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
Macroautophagy/autophagy inhibition is a novel anticancer therapeutic strategy, especially for tumors driven by mutant RAS. Here, we demonstrate that autophagy inhibition in RAS-mutated cells induces epithelial-mesenchymal transition (EMT), which is associated with enhanced tumor invasion. This is a...
Main Authors: | Wang, Y, Xiong, H, Liu, D, Hill, C, Ertay, A, Li, J, Zou, Y, Miller, P, White, E, Downward, J, Goldin, R, Yuan, X, Lu, X |
---|---|
Format: | Journal article |
Published: |
Taylor and Francis
2019
|
Similar Items
-
ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer
by: Liu, D, et al.
Published: (2020) -
Autophagy inhibition-mediated epithelial–mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis
by: Hill, C, et al.
Published: (2019) -
The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion
by: Jian Yang, et al.
Published: (2023-08-01) -
FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition
by: Zhang X, et al.
Published: (2019-02-01) -
The interplay of autophagy and epithelial-to-mesenchymal transition in cancer progression
by: O. O. Ryabaya, et al.
Published: (2020-09-01)